Clinical Trials Browser

Polycystic Ovary Syndrome

NCT01794793 2024-10-01

Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies

Acromegaly, Dumping Syndrome, Melanoma, Neoplasms, Pituitary Neoplasms, Prostatic Neoplasms, Neuroendocrine Tumors, Pituitary ACTH Hypersecretion

NCT01730729 2019-09-17

Cabergoline in Metastatic Breast Cancer

Phase EARLY_PHASE1 Completed

20 enrolled 11 charts

Breast

Breast Neoplasms

NCT03271918 2017-09-07

Cabergoline in Nonfunctioning Pituitary Adenomas

Phase 3 Completed

140 enrolled

Endocrine

Pituitary Neoplasms

NCT00376064 2017-03-06

Efficacy of Octreotide Acetate and Cabergoline in Patients With Acromegaly

Phase 4 Completed

20 enrolled

CNSEndocrine

Acromegaly, Brain Neoplasms, Pituitary Neoplasms

NCT01620138 2016-08-22

Response to Cabergoline and Pasireotide in Non-functioning Pituitary Adenomas and Resistant Prolactinomas

Phase 2/3 Completed

21 enrolled 4 charts

Prolactinoma

NCT01569256 2012-04-04

Ovarian Hyperstimulation Syndrome and Cabergoline

Phase NA Completed

40 enrolled

Gynecologic

Polycystic Ovary Syndrome, Ovarian Hyperstimulation Syndrome

NCT00889525 2009-04-29

Study of Cabergoline in Treatment of Corticotroph Pituitary Tumor

Phase 3 Completed

Endocrine

Pituitary ACTH Hypersecretion, ACTH-Secreting Pituitary Adenoma

NCT00460616 2008-04-16

ValveCab

Completed

50 enrolled

Heart Valve Diseases, Prolactinoma

Clinical Trials

Letrozole and Cabergoline Versus Letrozole Alone in Ovulation Induction